Asian Stocks Edge Higher as Tech Shares Rise Ahead of Trump-Xi Beijing Summit 
Elon Musk’s China Influence Faces New Challenges Amid Rising EV Competition 
SoftBank Shares Slide Despite Record Q4 Profit Fueled by OpenAI Investment 
Cisco Restructures for AI Growth After Record Q3 Revenue 
Telefónica Q1 2026 Earnings Beat Expectations as Debt Declines and Cash Flow Improves 
Alphabet Raises Record $3.6 Billion in Yen Bonds to Support AI Expansion 
Japan’s Top Banks to Gain Access to Anthropic’s Claude Mythos AI Model 
Dollar Surges as Inflation Data Fuels Fed Rate Hike Expectations 
Alibaba Stock Surges After Strong Q4 Earnings Boosted by AI and Cloud Growth 
Asia-Pacific Banks Brace for Rising Credit Risks Amid Iran Conflict 
Trump and Xi Temple of Heaven Visit Highlights Trade and Diplomacy Goals 
Trump, Xi Begin High-Stakes China Summit Focused on Trade, Taiwan and Global Tensions 
BlackRock-Led GCC Infrastructure Partnership Targets $30 Billion Investment 
US, Japan Reaffirm Strong Currency Coordination Amid Yen Volatility 
US-China Trade Talks Begin in South Korea Ahead of Trump-Xi Beijing Summit 
EQT Launches $3.76 Billion Take-Private Deal for Kakaku.com as Shares Surge 
Anthropic Nears $30 Billion Funding Round at $900 Billion Valuation 
Kakao Healthcare Corp. and Dexcom Inc. have embarked on a groundbreaking partnership to provide continuous glucose monitoring (CGM) for diabetes patients, starting in South Korea with plans for global expansion.
Kakao Healthcare and Dexcom are looking to offer sugar management services in South Korea first and then expand globally. Their target is to provide the CGM glucose management service in more countries next year.
As per The Korea Economic Daily, with the tie-up, Kakao Corporation's healthcare arm just took another step forward in bringing its business into key markets outside Korea. This strategic partnership with Dexcom will help it provide digital blood sugar management services using Kakao Healthcare's software and artificial intelligence technology.
"We will achieve global expansion of K-digital healthcare while making efforts to promote public health and create social values in South Korea," Hwang Hee, Kakao Healthcare's chief executive officer, said in a statement.
The Korea Times further quoted the CEO as saying, "The agreement with Dexcom will enable us to launch our innovative CGM-based blood glucose management service domestically and expand globally. As a member of Kakao, we will strive to improve public health and create social value in Korea and achieve global expansion of Korea's digital healthcare industry."
Meanwhile, it was in April this year when Kakao Healthcare and Dexcom first met up to sign the memorandum of understanding in Boston. They expanded their contract and agreed to pursue a joint global business this time and will promote a personalized digital blood glucose management service together.
Kakao Healthcare and Dexcom are launching the new CGM service in the fourth quarter of this year in Korea, then gradually adding more countries. "By combining Kakao Healthcare's software and AI technology capabilities with Dexcom's continuous glucose monitoring (CGM) hardware capabilities, the two companies will provide innovative blood glucose management solutions," the Korean firm said.
Photo by: Kakao Newsroom
